Search results for: 'cases dosag learning'

A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

08 Sep 2016  |  Global  |  Market Research

Growth Opportunities for Healthcare Big Data—An Analysis of Global Case Studies

Big Data Initiatives Targeted at Health Prediction and Precision

Infographics

×

The healthcare industry has been a laggard in Big Data adoption as compared to other verticals and continues to battle challenges around interoperability, budget constraints, and insufficient strategic planning and change management. However, the intent to leverage the power of Big Data is evident across all industry stakeholders, including governm...

09 Sep 2025  |  Global  |  Technology Research

Mixed Reality in Healthcare, Global, 2025–2029

Mixed Reality in Healthcare Is Driving Transformational Growth Through Medical Education, Emerging Growth Opportunities, Global Ecosystems, and Advanced Technology Analysis

Infographics

×

Mixed reality (MR) merges real and virtual elements to create interactive environments. Workforce shortages, rising training needs, patient engagement gaps, and the shift toward decentralized care are driving demand for immersive technologies in healthcare. By blending virtual and augmented reality, MR enables learners to practice complex clinical ...

Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...

Mental health conditions reduce people’s life expectancy—yet mental health takes a distant second place to physical health in many instances. This is slowly changing after the COVID-19 pandemic triggered rising cases of anxiety and depression, as have other geopolitical conditions and natural calamities. With rising awareness, new treatments em...

The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward specialized development and manufacturing capabilities ...

Artificial intelligence (AI) is exhibiting real promise across multiple industries. The healthcare industry is leading the charge when it comes to focused AI application development and attracting AI investment globally. With improvements in healthcare data acquisition and computing power, AI is becoming more of a reality each day. Frost & Sullivan...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, medical imaging, digital health and diagnostics industry. The issue includes advanced medical devices such as artificial intelligence-powered linear accelerator (Linac), left ventricular assist device, nex...

Traditional training environments face patient safety risks, resource constraints, and limited exposure to rare event scenarios. Additionally, physical simulations are costly, limiting accessibility (especially in resource-constrained settings). Current simulation models lack personalization, resulting in operational complexity for hospitals due to...